Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Abstract 5702: Ovarian cancer tumor microenvironment and atezolizumab (atezo) clinical activity: IMagyn050 sub-study

Venkatesh Krishnan, Ching-Wei Chang, Habib Hamidi, Michael A. Bookman, Charles Landen, Tashanna Myers, Hiroaki Kajiyama, Sakari Hietanen, Lyndsay Willmott, Premal Thaker, Cagatay Taskiran, Jalid Sehouli, Victor Khor, Yvonne Lin Liu, Sandro Pignata, Kathleen Moore, Luciana Molinero

Cancer Res (2023) 83 (7_Supplement): 5702.

https://doi.org/10.1158/1538-7445.AM2023-5702

Published: 04 April 2023

View article titled, Abstract 5702: Ovarian cancer tumor microenvironment and atezolizumab (atezo) clinical activity: IMagyn050 sub-study

Journal Articles

Abstract 5708: HOXA4 and HOXB3 gene expression signature as a biomarker of tumor recurrence in patients with high-grade serous ovarian cancer (HGSOC) following primary cytoreductive surgery and first-line adjuvant chemotherapy

Jai N. Patel, Katherine Miller, James Symanowski, Jalid Sehouli, Chad Michener, Ioana Braicu, Darla Destephanis, Ashley P. Sutker, Eric J. Norris, David Tait, Wendell Jones, Qing Zhang, Chad Livasy, Charles Biscotti, Ram N. Ganapathi, Mahrukh K. Ganapathi

Cancer Res (2017) 77 (13_Supplement): 5708.

https://doi.org/10.1158/1538-7445.AM2017-5708

Published: 01 July 2017

View article titled, Abstract 5708: <em>HOXA4 and HOXB3</em> gene expression signature as a biomarker of tumor recurrence in patients with high-grade serous ovarian cancer (HGSOC) following primary cytoreductive surgery and first-line adjuvant chemotherapy

Journal Articles

Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas

Mika Hilvo, Ines de Santiago, Peddinti Gopalacharyulu, Wolfgang D. Schmitt, Jan Budczies, Marc Kuhberg, Manfred Dietel, Tero Aittokallio, Florian Markowetz, Carsten Denkert, Jalid Sehouli, Christian Frezza, Silvia Darb-Esfahani, Elena Ioana Braicu

Cancer Res (2016) 76 (4): 796–804.

https://doi.org/10.1158/0008-5472.CAN-15-2298

Published: 14 February 2016

View article titled, Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas

Includes: Supplementary data

Journal Articles

Polo-like Kinase Plk2 Is an Epigenetic Determinant of Chemosensitivity and Clinical Outcomes in Ovarian Cancer

Nelofer Syed, Helen M. Coley, Jalid Sehouli, Dominique Koensgen, Alexander Mustea, Peter Szlosarek, Iain McNeish, Sarah P. Blagden, Peter Schmid, David P. Lovell, Eleftheria Hatzimichael, Tim Crook

Cancer Res (2011) 71 (9): 3317–3327.

https://doi.org/10.1158/0008-5472.CAN-10-2048

Published: 29 April 2011

View article titled, Polo-like Kinase Plk2 Is an Epigenetic Determinant of Chemosensitivity and Clinical Outcomes in Ovarian Cancer

Includes: Supplementary data

Journal Articles

Abstract 4723: Soluble L1-CAM in the ascites is a prognostic marker in ovarian cancer

Sandra Bondong, Thomas Hielscher, Alain Zeimet, Robert Zeillinger, Isabelle Cadron, Jalid Sehouli, Ignace Vergote, Sven Mahner, Paul Speiser, Ioana Braicu, Monica Huszar, Mina Fogel, Peter Altevogt

Cancer Res (2011) 71 (8_Supplement): 4723.

https://doi.org/10.1158/1538-7445.AM2011-4723

Published: 15 April 2011

View article titled, Abstract 4723: Soluble L1-CAM in the ascites is a prognostic marker in ovarian cancer

Journal Articles

An Illegitimate microRNA Target Site within the 3′ UTR of MDM4 Affects Ovarian Cancer Progression and Chemosensitivity

Cancer Res (2010) 70 (23): 9641–9649.

https://doi.org/10.1158/0008-5472.CAN-10-0527

Published: 06 December 2010

View article titled, An Illegitimate microRNA Target Site within the 3′ UTR of <em>MDM4</em> Affects Ovarian Cancer Progression and Chemosensitivity

Includes: Supplementary data

Journal Articles

Methylation reversal reveals Snk/PLK2 as a critical determinant of clinical outcome in ovarian cancer

Nelofar Syed, Helen Coley, Jalid Sehouli, Dominique Koensgen, Alexander Mustea, Peter Slozarek, Iain McNeish, Peter Schmid, Tim Crook

Cancer Res (2008) 68 (9_Supplement): 230.

Published: 01 May 2008

View article titled, Methylation reversal reveals Snk/PLK2 as a critical determinant of clinical outcome in ovarian cancer

Journal Articles

NFkappaB subunit p65/RelA expression is a prognostic marker in human ovarian carcinoma and linked to COX-2 overexpression in vivo and in vitro

Silvia Niesporek, Wilko Weichert, Bruno Sinn, Annika Roske, Aurelia Noske, Ann-Christin Buckendahl, Jalid Sehouli, Dominique Konsgen, Manfred Dietel, Carsten Denkert

Cancer Res (2007) 67 (9_Supplement): 2693.

Published: 01 May 2007

View article titled, NFkappaB subunit p65/RelA expression is a prognostic marker in human ovarian carcinoma and linked to COX-2 overexpression in vivo and in vitro

Journal Articles

Mass Spectrometry–Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline Tumors

Carsten Denkert, Jan Budczies, Tobias Kind, Wilko Weichert, Peter Tablack, Jalid Sehouli, Silvia Niesporek, Dominique Könsgen, Manfred Dietel, Oliver Fiehn

Cancer Res (2006) 66 (22): 10795–10804.

https://doi.org/10.1158/0008-5472.CAN-06-0755

Published: 15 November 2006

View article titled, Mass Spectrometry–Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline Tumors

Includes: Supplementary data

Journal Articles

LPAAT-β expression in human ovarian carcinoma is associated with tumor grading and prognosis

Silvia Niesporek, Wilko Weichert, Martin Köbel, Aurelia Noske, Jalid Sehouli, Jack W. Singer, Manfred Dietel, Steffen Hauptmann, Carsten Denkert

Cancer Res (2005) 65 (9_Supplement): 1152–1153.

Published: 01 May 2005

View article titled, LPAAT-β expression in human ovarian carcinoma is associated with tumor grading and prognosis

Journal Articles

Transthyretin, a Biomarker for Nutritional Status and Ovarian Cancer

Florian J. Schweigert, Jalid Sehouli

Cancer Res (2005) 65 (3): 1114.

https://doi.org/10.1158/0008-5472.1114.65.3

Published: 10 February 2005

View article titled, Transthyretin, a Biomarker for Nutritional Status and Ovarian Cancer

Journal Articles

Expression of the ELAV-like protein HuR in ovarian carcinoma - association with cell proliferation as well as COX-2 expression

Carsten Denkert, Wilko Weichert, Sören Pest, Ines Koch, Dirk Licht, Martin Köbel, Angela Reles, Jalid Sehouli, Manfred Dietel, Steffen Hauptmann

Cancer Res (2004) 64 (7_Supplement): 242.

Published: 01 April 2004

View article titled, Expression of the ELAV-like protein HuR in ovarian carcinoma - association with cell proliferation as well as COX-2 expression

Journal Articles

Overexpression of the Embryonic-Lethal Abnormal Vision-like Protein HuR in Ovarian Carcinoma Is a Prognostic Factor and Is Associated with Increased Cyclooxygenase 2 Expression

Carsten Denkert, Wilko Weichert, Sören Pest, Ines Koch, Dirk Licht, Martin Köbel, Angela Reles, Jalid Sehouli, Manfred Dietel, Steffen Hauptmann

Cancer Res (2004) 64 (1): 189–195.

https://doi.org/10.1158/0008-5472.CAN-03-1987

Published: 16 January 2004

View article titled, Overexpression of the Embryonic-Lethal Abnormal Vision-like Protein HuR in Ovarian Carcinoma Is a Prognostic Factor and Is Associated with Increased Cyclooxygenase 2 Expression

NARROW

Abstract 5702: Ovarian cancer tumor microenvironment and atezolizumab (atezo) clinical activity: IMagyn050 sub-study

Abstract 5708: HOXA4 and HOXB3 gene expression signature as a biomarker of tumor recurrence in patients with high-grade serous ovarian cancer (HGSOC) following primary cytoreductive surgery and first-line adjuvant chemotherapy

Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas

Polo-like Kinase Plk2 Is an Epigenetic Determinant of Chemosensitivity and Clinical Outcomes in Ovarian Cancer

Abstract 4723: Soluble L1-CAM in the ascites is a prognostic marker in ovarian cancer

An Illegitimate microRNA Target Site within the 3′ UTR of MDM4 Affects Ovarian Cancer Progression and Chemosensitivity

Methylation reversal reveals Snk/PLK2 as a critical determinant of clinical outcome in ovarian cancer

NFkappaB subunit p65/RelA expression is a prognostic marker in human ovarian carcinoma and linked to COX-2 overexpression in vivo and in vitro

Mass Spectrometry–Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline Tumors

LPAAT-β expression in human ovarian carcinoma is associated with tumor grading and prognosis

Transthyretin, a Biomarker for Nutritional Status and Ovarian Cancer

Expression of the ELAV-like protein HuR in ovarian carcinoma - association with cell proliferation as well as COX-2 expression

Overexpression of the Embryonic-Lethal Abnormal Vision-like Protein HuR in Ovarian Carcinoma Is a Prognostic Factor and Is Associated with Increased Cyclooxygenase 2 Expression

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only